🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib study in healthy adults (18-70 years) to evaluate the sa...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-08
Trial ID
NCT01676402
Treatments Being Tested
The hypothesis proposed in this study is that the 2011-2012 Seasonal Influe...
Status
Unknown
Location
National Institute of Public Health
Start Date
2012-04
Trial ID
NCT01577316
Treatments Being Tested
A new flu vaccine which is injected into the skin instead of into the muscl...
Status
Completed
Location
National Jewish Health
Start Date
2011-11
Trial ID
NCT01518478
Treatments Being Tested
The aim of the study is to evaluate the safety and immunogenicity of the 20...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01430819
The purpose of this study is to investigate the responses to licensed triva...
Status
Completed
Location
Stanford LPCH Vaccine Program
Start Date
2011-08
Trial ID
NCT02141581
Treatments Being Tested
This study will evaluate safety and immunogenicity of a sub-unit Influenza ...
Status
Completed
Location
Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio
Start Date
2011-05
Trial ID
NCT01357265
Treatments Being Tested
The aim of the study is to assess the safety profile of a quadrivalent infl...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01481454
A randomized, double-blinded, Phase II study in adults with Rheumatoid Arth...
Status
Completed
Location
University of Iowa - Vaccine Research & Education Unit
Start Date
2011-10
Trial ID
NCT01436370
Treatments Being Tested
The purpose of the study is to compare the immune response of two different...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01422200
Treatments Being Tested